# Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement

Source: https://onco.cc/trials/nct06073938/  
OnCo record `nct06073938` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

An trial of NHWD-870 run by Hunan Province Tumor Hospital, of unknown status on the registry.

## Summary

Compassionate Use Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement is an interventional study registered as NCT06073938 by Hunan Province Tumor Hospital, with 30 participants planned, started 2022-09-20. Conditions recorded: Advanced Solid Tumors or Lymphomas. Interventions recorded: NHWD-870.

## Fields

- Kind: Trial
- Status: historic
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06073938
- Phase: not-applicable
- Setting: A Real-World Study of NHWD-870 in Patients With Advanced Solid Tumors or Lymphomas Carrying NUT Rearrangement
- Sponsor: Hunan Province Tumor Hospital
- Enrolled: 30

## Sources

- ClinicalTrials.gov NCT06073938: https://clinicaltrials.gov/study/NCT06073938

## Connected records

- cancers: [Non-Hodgkin lymphoma (all types)](https://onco.cc/cancers/non-hodgkin-lymphoma/)
- drugs: [NHWD-870](https://onco.cc/drugs/nhwd-870/)
- companies: [Zhejiang Wenda Pharma](https://onco.cc/companies/zhejiang-wenda-pharma/)

---
JSON: https://onco.cc/api/v1/entities/nct06073938.json